Bristol-Myers Squibb BMY Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.68B+8.8% | $1.09B— | $2.2B+80.7% | $1.31B-22.0% | $2.46B+121% | ||
| $594M-41.3% | $977M-48.0% | $1.01B-61.0% | $1.01B-61.1% | $1.01B-60.0% | ||
| $146M+1.4% | $133M+10.8% | $139M+7.8% | $137M+9.6% | $144M+8.3% | ||
| $1.1B-43.5% | $1.97B-55.5% | $6.31B+12.9% | $3.92B+68.4% | $1.95B-31.1% | ||
| $347M+33.5% | $370M-2.1% | $320M-1.2% | $361M+37.8% | $260M-8.5% | ||
| $65M-16.7% | $1.71B+3,532% | $1.87B+439% | $285M-79.2% | $78M-99.6% | ||
| -$131M+73.7% | -$1.46B-644% | -$1.7B-677% | -$473M+64.1% | -$499M+97.5% | ||
| $1.28B+2.0% | $1.26B+3.6% | $1.26B+3.9% | $1.26B+3.7% | $1.26B+3.8% | ||
| $500M— | $10.07B— | $229M-90.8% | $643M+62.8% | $0— | ||
| -$1.56B-57.1% | -$6.03B— | -$1.49B— | -$1.84B— | -$993M-107% | ||
| -$635M-220% | -$5.51B— | $3.12B— | $1.74B+157% | $528M+124% | ||
| $757M-55.3% | $1.6B-60.5% | $5.99B+13.7% | $3.56B+72.3% | $1.69B-33.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bristol-Myers Squibb generate?
- Bristol-Myers Squibb (BMY) generated $13.3B in operating cash flow over the trailing twelve months.
- What is Bristol-Myers Squibb's free cash flow?
- After $1.4B of capital expenditures, Bristol-Myers Squibb's free cash flow was $11.9B over the trailing twelve months, down 9.0% year over year.
- Where does Bristol-Myers Squibb's cash flow data come from?
- Every line is extracted from Bristol-Myers Squibb's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
